Skip to content

Treating bulimia nervosa in female adolescents with either cognitive-behavioral therapy (CBT) or psychodynamic therapy (PDT)

A randomized controlled multi-center study for treating bulimia nervosa in female adolescents with cognitive-behavioral therapy (CBT) versus psychodynamic therapy (PDT)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14806095
Enrollment
70
Registered
2017-02-03
Start date
2007-01-01
Completion date
Unknown
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bulimia nervosa Mental and Behavioural Disorders Bulimia nervosa

Interventions

Participants are randomly assigned to receive one of two treatments using block randomization, which was conducted by a research assistant who was not involved in the diagnostic procedures or outcome

Sponsors

VAKJP / Association of psychoanalytic child- and adolescent-psychotherapists in Germany
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Females between the age of 14 and 20 years old 2. Diagnosis of bulimia nervosa according to the critieria in the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) 3. Diagnosis of partial bulimia nevosa which includes participants who binged and purged less than two times per week in three months

Exclusion criteria

Exclusion criteria: 1. Diagnosis of anorexia nervosa 2. Other severe physical or mental conditions such as current psychosis, alcohol or drug abuse or addiction, suicidal, and attention deficit hyperactivity disorder (ADHD) 3. An IQ<80 4. Current psychotherapeutic or psychotropic treatment

Design outcomes

Primary

MeasureTime frame
Severity of the eating disorder is assessed by the German version of EDE 27 at baseline, session 15, 30, 45 and 60 (end of therapy) and 6 and 12 months post-treatment.

Secondary

MeasureTime frame
1. Self-evaluated psychopathologies of the eating disorder is measured using the EDE Questionnaire (EDE-Q) at baseline, session 15, 30, 45 and 60 (end of therapy) and 6 and 12 months post-treatment 2. Overall severity of mental symptoms is assessed using the Symptom Check List (SCL-90-R) at baseline, session 15, 30, 45 and 60 (end of therapy) and 6 and 12 months post-treatment

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 10, 2026